评论 9
过滤器:
评分
语言
种类:
最近的
H
5 几个月前

I have been using echosens.us products for a while...

I have been using echosens.us products for a while now and I am very impressed with their quality. The team at echosens.us is always responsive and helpful, making the whole experience even better. I highly recommend their products to anyone in the healthcare industry.

J
6 几个月前

I recently purchased a product from this company a...

I recently purchased a product from this company and I am extremely satisfied. The product is of high quality and the customer service was exceptional. I would definitely recommend it to others!

S
8 几个月前

Echosens North America is an exceptional company. ...

Echosens North America is an exceptional company. Their dedication to providing high-quality products and excellent customer service is unmatched. I had the pleasure of working with their team and I was impressed by their professionalism and attention to detail. The products they offer are innovative and truly make a difference in the healthcare industry. I highly recommend Echosens North America to anyone in need of reliable and efficient healthcare solutions.

A
1年以前

I recently purchased a product from echosens.us an...

I recently purchased a product from echosens.us and I am extremely satisfied with my experience. The customer service was excellent and they went above and beyond to ensure that I was happy with my purchase. The product itself is of high quality and has exceeded my expectations. I would definitely recommend echosens.us to others!

关于Echosens north america

Echosens North America:使用 FibroScan® 革新肝病管理

Echosens North America 是一家领先的医疗技术公司,专门开发和制造 FibroScan ®,这是一种用于准确测量肝脏硬度和肝脏脂肪变性的非侵入性解决方案。该公司的使命是为医疗保健专业人员提供创新工具,使他们能够更好地管理肝病、改善患者预后并降低医疗保健成本。

肝病是一个日益严重的全球健康问题,影响着全世界数百万人。它可以由多种因素引起,例如酗酒、病毒性肝炎、肥胖和代谢紊乱。早期发现和管理对于防止肝病发展为更严重的疾病(例如肝硬化或肝细胞癌)至关重要。

FibroScan® 是一种先进的诊断工具,它使用获得专利的振动控制瞬时弹性成像 (VCTE) 技术来无创测量肝脏硬度。该过程包括在患者仰卧时将一个小探针放在覆盖肝脏区域的皮肤上。探头发出低频振动,在肝组织中产生剪切波。然后,探头中的传感器会测量这些波,以确定肝脏中存在的硬度或纤维化程度。

FibroScan® 还测量受控衰减参数 (CAP),该参数评估肝脏中的脂肪堆积或脂肪变性。这些信息为临床医生提供了对患者整体肝脏健康状况的宝贵见解,并有助于指导治疗决策。

FibroScan® 与活检等传统方法相比的主要优势之一是其非侵入性,这消除了与侵入性操作相关的许多风险,例如出血或感染。此外,FibroScan® 可立即提供结果,无需住院或麻醉。

自 2001 年由 Laurent Sandrin 和 Jonel Trebicka 博士创立以来,Echosens North America 一直处于开发管理慢性肝病创新解决方案的前沿。该公司业务遍及全球,在欧洲、亚洲和北美设有办事处。

FibroScan® 已在全球众多临床研究中得到广泛验证,并被公认为评估肝脏硬度和脂肪变性的可靠工具。欧洲肝病研究协会 (EASL) 和美国肝病研究协会 (AASLD) 等主要国际肝病管理指南均推荐使用该药物。

Echosens North America 对创新的承诺超越了 FibroScan®。该公司还提供补充解决方案,例如 FibroView®,这是一种软件应用程序,使临床医生能够远程查看和解释 FibroScan® 结果,从而加强患者护理协调。

总之,Echosens North America 是一家领先的医疗技术公司,为医疗保健专业人员提供有效管理慢性肝病的创新工具。其旗舰产品 FibroScan® 是一种先进的诊断工具,使用非侵入式 VCTE 技术准确测量肝脏硬度和脂肪变性。凭借对创新和患者护理协调的承诺,Echosens North America 继续革新我们在全球管理慢性肝病的方式。

已翻译
Echosens north america

Echosens north america

4.2